BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,433,000 | -58.8% | 23,559 | -66.5% | 0.01% | -47.1% |
| Q1 2022 | $8,336,000 | +22.4% | 70,302 | +42.3% | 0.02% | +30.8% |
| Q4 2021 | $6,808,000 | -62.9% | 49,404 | -62.7% | 0.01% | -64.9% |
| Q3 2021 | $18,375,000 | +3.5% | 132,279 | -27.7% | 0.04% | +8.8% |
| Q2 2021 | $17,753,000 | +23.6% | 182,867 | -13.0% | 0.03% | +17.2% |
| Q1 2021 | $14,364,000 | -7.4% | 210,140 | +16.1% | 0.03% | -6.5% |
| Q4 2020 | $15,517,000 | +16.2% | 181,043 | -11.9% | 0.03% | +3.3% |
| Q3 2020 | $13,355,000 | -11.9% | 205,438 | -1.0% | 0.03% | -14.3% |
| Q2 2020 | $15,167,000 | +51.3% | 207,462 | -29.6% | 0.04% | +29.6% |
| Q1 2020 | $10,027,000 | -32.9% | 294,658 | +7.3% | 0.03% | -12.9% |
| Q4 2019 | $14,947,000 | -13.4% | 274,548 | -33.6% | 0.03% | -18.4% |
| Q3 2019 | $17,254,000 | +53.6% | 413,580 | +61.2% | 0.04% | +58.3% |
| Q2 2019 | $11,232,000 | +1671.6% | 256,501 | +1981.0% | 0.02% | +2300.0% |
| Q1 2019 | $634,000 | +43.1% | 12,326 | +2.9% | 0.00% | 0.0% |
| Q4 2018 | $443,000 | -3.5% | 11,975 | -2.1% | 0.00% | 0.0% |
| Q3 2018 | $459,000 | -9.6% | 12,235 | -4.8% | 0.00% | 0.0% |
| Q2 2018 | $508,000 | +46.4% | 12,855 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $347,000 | – | 13,457 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |